Ionis Pharmaceuticals Inc
IONS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000874015
In the last 90 days, Ionis Pharmaceuticals Inc insiders filed 1 open-market purchase and 2 sales; 464 institutions reported holding it in 13F filings for Q3 2026, worth $7.66B in total; ARK Invest is the only superinvestor holding it.
Holders of 5% or more of IONS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ionis Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Capital World Investors | 13G/A | 12.80%21.2M shares | +1.70 ppfrom 11.10% | Feb 13, 20253 filings | May 14, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 5.70%9.07M shares | – | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 5.05%8.34M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
40 Schedule 13D and 13G filings on Ionis Pharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 202610:06 AM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 3.70%6.16M shares | −1.90 ppfrom 5.60%Below 5% | Mar 31, 2026 | SEC |
| May 14, 20261:55 PM ET | Capital World Investors | 13G/A | 12.80%21.2M shares | +1.70 ppfrom 11.10% | Mar 31, 2026 | SEC |
| Apr 30, 202611:07 AM ET | Vanguard Capital Management LLC | 13G | 5.05%8.34M shares | New | Mar 31, 2026 | SEC |
| Mar 27, 20269:52 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −10.43 ppfrom 10.43%Below 5% | Mar 13, 2026 | SEC |
| Feb 17, 202610:28 AM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 5.60%9.11M shares | −2.70 ppfrom 8.30% | Dec 31, 2025 | SEC |
| Jan 7, 20267:48 PM ET | Capital World Investors | 13G/A | 11.10%18.0M shares | +3.80 ppfrom 7.30% | Dec 31, 2025 | SEC |
| Nov 14, 202512:18 PM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 8.30%13.2M shares | −1.70 ppfrom 10.00% | Sep 30, 2025 | SEC |
| Aug 12, 202510:34 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 4.30%6.88M shares | –Below 5% | Jun 30, 2025 | SEC |
| Apr 17, 20259:35 AM ET | BlackRock, Inc. | 13G/A | 5.70%9.07M shares | – | Mar 31, 2025 | SEC |
| Feb 13, 20254:53 PM ET | Capital World Investors | 13G | 7.30%11.5M shares | New | Dec 31, 2024 | SEC |
| Feb 7, 202511:55 AM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 10.00%15.9M shares | – | Jan 31, 2025 | SEC |
| Jan 8, 202511:29 AM ET | Vanguard Group Inc | 13G/A | 10.43%16.5M shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | T. Rowe Price Investment Management, Inc. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | Wellington Management Group LLP | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | T. Rowe Price Investment Management, Inc. | 13GOld format | – | – | – | SEC |
| Feb 13, 2024 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 26, 20244:25 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jun 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | T. Rowe Price Investment Management, Inc. | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 31, 20235:52 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Aug 10, 2022 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Apr 11, 2022 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | ARK Investment Management LLCSuperinvestorARK Invest | 13GOld format | – | New | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20225:08 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 16, 2021 | Price T Rowe Associates Inc | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | BB Biotech AG | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2021 | Clearbridge Investments, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 5, 20217:51 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
188 notices from officers, directors and other affiliates planning to sell Ionis Pharmaceuticals Inc shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Oct 16, 20265:16 PM ET | Devers Shannon L.Officer | 1.36K | $59.7K | Oct 16, 2026 | Morgan Stanley Smith Barney | SEC |
| Jul 7, 20264:33 PM ET | Diaz Allene M.Director | 10.1K | $863.6K | Jul 7, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Jul 7, 20264:30 PM ET | Kordasiewicz Holly B.Officer | 1.29K | $108.5K | Jul 7, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Jul 7, 20264:28 PM ET | Bennett C FrankOfficer | 67.4K | $5.72M | Jul 7, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Jul 1, 20265:29 PM ET | Klein Joseph IIIDirector | 11.5K | $910.4K | Jul 1, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Jun 26, 20265:48 PM ET | Baroldi MarianaFamily member of an insider | 5.63K | $451.7K | Jun 26, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Jun 26, 20265:47 PM ET | O'Neil Patrick R.Officer | 3.07K | $245.5K | Jun 26, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Jun 26, 20265:43 PM ET | Schneider EugeneOfficer | 47.9K | $3.88M | Jun 26, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Jun 25, 20266:53 PM ET | Swayze EricOfficer | 10.6K | $839.3K | Jun 25, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Jun 15, 202610:17 AM ET | Berthelsen Spencer RDirector | 8.00K | $587.9K | Jun 15, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| Jun 12, 20264:29 PM ET | Kordasiewicz Holly B.Officer | 60.8K | $4.47M | Jun 12, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Jun 1, 202610:47 AM ET | Berthelsen Spencer RDirector | 8.00K | $605.4K | Jun 1, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| May 13, 20265:20 PM ET | Monia Brett POfficer | 100.0K | $7.80M | May 13, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| May 4, 20266:05 PM ET | Loscalzo JosephDirector | 54.3K | $4.35M | May 4, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Apr 28, 20264:12 PM ET | Baroldi JosephOfficer | 1.63K | $116.7K | Apr 28, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Apr 16, 20266:49 PM ET | Jenne KyleOfficer | 4.90K | $369.6K | Apr 16, 2026 | Morgan Stanley Smith Barney | SEC |
| Apr 16, 20266:47 PM ET | Birchler BrianOfficer | 973 | $73.4K | Apr 16, 2026 | Morgan Stanley Smith Barney | SEC |
| Apr 16, 20266:45 PM ET | Baroldi JosephOfficer | 5.62K | $423.7K | Apr 16, 2026 | Morgan Stanley Smith Barney | SEC |
| Mar 31, 20265:28 PM ET | Diaz Allene M.Director | 68.8K | $5.47M | Mar 3, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Mar 24, 20264:43 PM ETAmended | Schneider EugeneOfficer | 5.81K | $412.5K | Mar 19, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Mar 16, 20264:32 PM ET | Hougen Elizabeth LOfficer | 225.2K | $16.3M | Mar 16, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Mar 10, 20264:00 PM ET | Jenne KyleDirector | 58.3K | $4.40M | Mar 10, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Mar 9, 20264:16 PM ET | O'Neil Patrick R.Officer | 13.2K | $994.6K | Mar 9, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Mar 3, 20265:52 PM ETAmended | Bennett C FrankOfficer | 85.1K | $7.06M | Mar 3, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Mar 3, 20265:51 PM ET | Loscalzo JosephDirector | 24.0K | $1.92M | Mar 3, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
Showing the latest 25. See the IONS notices from the last 12 months